Undefined-Antigen Vaccines
作者： Hong-Ming Hu , Yiwei Chu , Walter J. Urba
关键词: Antitumor immunity 、 Tumor antigen 、 Advanced cancer 、 Antigen 、 Tumor cells 、 Computational biology 、 Effective treatment 、 Standard therapy 、 Medicine
摘要: Our knowledge of the immune system and how it interacts with tumor cells continues to grow. With each advance in basic science comes a new opportunity develop an effective treatment strategy. Many such opportunities have arisen past few decades this chapter has attempted describe these advances been combined variety undefined cellular antigen preparations attempt cancer vaccines. None strategies described sufficiently become part standard therapy. However, approaches tested generally well-tolerated by patients advanced evidence immunologic activity examples impressive clinical wide malignancies, suggests that can be building blocks upon which are added treatments developed.
springer.com
sci-hub.st 参考文章(121)
Ira Mellman, Ralph M. Steinman, Dendritic cells: specialized and regulated antigen processing machines. Cell. ,vol. 106, pp. 255- 258 ,(2001) , 10.1016/S0092-8674(01)00449-4
Jens Dannull, Johannes Vieweg, Donna Niedzwiecki, Eli Gilboa, Axel Heiser, Scott Pruitt, Donna Yancey, John Madden, Doris Coleman, Zhen Su, Immunological and Clinical Responses in Metastatic Renal Cancer Patients Vaccinated with Tumor RNA-transfected Dendritic Cells Cancer Research. ,vol. 63, pp. 2127- 2133 ,(2003)
F. M. Burnet, The concept of immunological surveillance. Progress in Experimental Tumor Research. ,vol. 13, pp. 1- 27 ,(1970) , 10.1159/000386035
Denise Darrah, Judith Abrams, Vicky Jones, Ulka Vaishampayan, Malcolm S. Mitchell, Active Immunotherapy of Metastatic Melanoma with Allogeneic Melanoma Lysates and Interferon α Clinical Cancer Research. ,vol. 8, pp. 3696- 3701 ,(2002)
Brian J. Nickoloff, Jeffrey S. Chamberlain, Dennis Hartigan-O’Connor, Martin Giedlin, Lea Aukerman, Christopher J. Kirk, James J. Mulé, T Cell-dependent Antitumor Immunity Mediated by Secondary Lymphoid Tissue Chemokine: Augmentation of Dendritic Cell-based Immunotherapy Cancer Research. ,vol. 61, pp. 2062- 2070 ,(2001)
Frank O. Nestle, Jacques Banchereau, Derek Hart, Dendritic cells: On the move from bench to bedside Nature Medicine. ,vol. 7, pp. 761- 765 ,(2001) , 10.1038/89863
Saburo Koshimura, Tsugiya Murayama, Kazuo Ryoyama, Effect of OK-432 on immunization with mitomycin-C-treated L1210 cells. GANN Japanese Journal of Cancer Research. ,vol. 70, pp. 75- 82 ,(1979) , 10.20772/CANCERSCI1959.70.1_75
Akio Hizuta, Heiichiro Udono, Pramod K. Srivastava, Toshiro Ono, Taketoshi Yamano, Noriaki Tanaka, Akiko Uenaka, Tatsuaki Ishii, Eiichi Nakayama, Hiroyuki Ohta, Isolation of MHC Class I-Restricted Tumor Antigen Peptide and Its Precursors Associated with Heat Shock Proteins hsp70, hsp90, and gp96 Journal of Immunology. ,vol. 162, pp. 1303- 1309 ,(1999)
Christopher V. Nicchitta, Re-evaluating the role of heat-shock protein-peptide interactions in tumour immunity. Nature Reviews Immunology. ,vol. 3, pp. 427- 432 ,(2003) , 10.1038/NRI1089
Walter J. Urba, Hong-Ming Hu, Bernard A. Fox, Gene-Modified Tumor Vaccine with Therapeutic Potential Shifts Tumor-Specific T Cell Response from a Type 2 to a Type 1 Cytokine Profile Journal of Immunology. ,vol. 161, pp. 3033- 3041 ,(1998)